Average Co-Inventor Count = 4.88
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (45 from 4,945 patents)
2. Siena Biotech S.p.a. (6 from 11 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
45 patents:
1. 9242943 - 1,4 oxazines as BACE1 and/or BACE2 inhibitors
2. 9079919 - Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as BACE1 and/or BACE2 inhibitors
3. 9073909 - [1,3]oxazines
4. 8877744 - 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
5. 8815881 - 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
6. 8815841 - 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
7. 8785436 - 1,3-oxazines as BACE 1 and/or BACE2 inhibitors
8. 8673894 - 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
9. 8399459 - 1,4 oxazines as BACE1 and/or BACE2 inhibitors
10. 8389513 - 2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides
11. 8367838 - Amines or amino alcohols as GLYT1 inhibitors
12. 8188079 - 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
13. 8188139 - Heterocyclic-substituted phenyl methanones
14. 8063098 - GlyT1 receptor antagonists
15. 7989449 - 4,5-dihydro-oxazol-2-yl amine derivatives